UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Space for Calaspargase? A New Asparaginase for Acute Lymphoblastic Leukemia

Clinical cancer research, 2020-01, Vol.26 (2), p.325-327

Lew, Glen

2020

Volltextzugriff (PDF)

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

Clinical cancer research, 2010-03, Vol.16 (6), p.1894-1903

2010

Volltextzugriff (PDF)

Incorporating Hemoglobin Levels to Map Leukostasis Risk in Acute Leukemia Using Microvasculature-on-Chip Technologies

Blood, 2020-11, Vol.136 (Supplement 1), p.9-10

2020

Volltextzugriff (PDF)

Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia

JAMA : the journal of the American Medical Association, 2015-02, Vol.313 (8), p.815

2015

Volltextzugriff (PDF)

Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL)

British journal of haematology, 2019-05, Vol.185 (3), p.613-616

2019

Volltextzugriff (PDF)

Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase

Blood, 2020-11, Vol.136 (Supplement 1), p.4-5

2020

Volltextzugriff (PDF)

Redefining Hyperviscosity in Acute Leukemia: Implications for Red Cell Transfusions

Blood, 2021-11, Vol.138 (Supplement 1), p.3253-3253

2021

Volltextzugriff (PDF)

Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report

Cancer, 2023-01, Vol.129 (1), p.151-160

2023

Volltextzugriff (PDF)

Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)

Blood, 2022-11, Vol.140 (Supplement 1), p.2183-2184

2022

Volltextzugriff (PDF)

Does Body Mass Index (BMI) during Maintenance Influence Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL)? Results from COG-AALL03N1

Blood, 2021-11, Vol.138 (Supplement 1), p.213-213

2021

Volltextzugriff (PDF)

Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis

Pediatric blood & cancer, 2016-04, Vol.63 (4), p.712-715

2016

Volltextzugriff (PDF)

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Blood, 2017-12, Vol.130, p.100-100

2017

Volltextzugriff (PDF)

“Russell-like” bodies in Philadelphia chromosome–positive B-lymphoblastic leukemia

Blood, 2014-04, Vol.123 (16), p.2448-2448

2014

Volltextzugriff (PDF)

Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction

Transfusion (Philadelphia, Pa.), 2018-05, Vol.58 (5), p.1149-1156

2018

Volltextzugriff (PDF)

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1730-1736

2017

Volltextzugriff (PDF)

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

JAMA oncology, 2015-06, Vol.1 (3), p.287

2015

Volltextzugriff (PDF)

Utility of peripheral blood immunophenotyping by flow cytometry in the diagnosis of pediatric acute leukemia

Pediatric blood & cancer, 2017-10, Vol.64 (10), p.n/a

2017

Volltextzugriff (PDF)

Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature

Journal of pediatric hematology/oncology, 2018-10, Vol.40 (7), p.e470-e472

2018

Volltextzugriff (PDF)

Parent participation and physician-parent communication during informed consent in child leukemia

Pediatrics (Evanston), 2011-12, Vol.128 (6), p.e1544

2011

Volltextzugriff (PDF)

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial

The Lancet. Haematology, 2024-01, Vol.11 (1), p.e27-e37

2024

Volltextzugriff (PDF)

A physician-directed intervention: teaching and measuring better informed consent

Academic medicine, 2009-08, Vol.84 (8), p.1036-1042

2009

Volltextzugriff (PDF)

A randomized trial of a mercaptopurine (6MP) adherence-enhancing intervention in children with acute lymphoblastic leukemia (ALL): A COG ACCL1033 study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.10007-10007

2019

Volltextzugriff (PDF)

Acute Neurotoxicity In Children with Acute Lymphoblastic Leukemia: An Association with Day-36 Intrathecal Methotrexate In Delayed Intensification

Blood, 2010-11, Vol.116 (21), p.3224-3224

2010

Volltextzugriff (PDF)

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

Journal of pediatric hematology/oncology, 2009-12, Vol.31 (12), p.936-941

2009

Volltextzugriff (PDF)

Comment on: Value of flow cytometric analysis of peripheral blood samples in children diagnosed with acute lymphoblastic leukemia

Pediatric blood & cancer, 2018-02, Vol.65 (2), p.n/a

2018

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(54)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(25)
Female
(20)
Child
(17)
Male
(17)
Oncology
(17)
Hematology
(14)
Child, Preschool
(12)
Pediatrics
(11)
Adolescent
(10)
Leukemia
(10)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(9)
Infant
(7)
All
(6)
Children
(6)
Acute Lymphoblastic Leukemia
(5)
Adult
(5)
Chemotherapy
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Space for Calaspargase? A New Asparaginase for Acute Lymphoblastic Leukemia

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

Incorporating Hemoglobin Levels to Map Leukostasis Risk in Acute Leukemia Using Microvasculature-on-Chip Technologies

Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia

Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL)

Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase

Redefining Hyperviscosity in Acute Leukemia: Implications for Red Cell Transfusions

Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report

Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)

Does Body Mass Index (BMI) during Maintenance Influence Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL)? Results from COG-AALL03N1

Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

“Russell-like” bodies in Philadelphia chromosome–positive B-lymphoblastic leukemia

Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Utility of peripheral blood immunophenotyping by flow cytometry in the diagnosis of pediatric acute leukemia

Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature

Parent participation and physician-parent communication during informed consent in child leukemia

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial

A physician-directed intervention: teaching and measuring better informed consent

A randomized trial of a mercaptopurine (6MP) adherence-enhancing intervention in children with acute lymphoblastic leukemia (ALL): A COG ACCL1033 study

Acute Neurotoxicity In Children with Acute Lymphoblastic Leukemia: An Association with Day-36 Intrathecal Methotrexate In Delayed Intensification

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

Comment on: Value of flow cytometric analysis of peripheral blood samples in children diagnosed with acute lymphoblastic leukemia

Suchergebnisse filtern